新規経口抗凝固剤（NOAC）のグローバル市場調査 2019年

• 英文タイトル：Global Novel Oral AntiCoagulants (NOAC) Market Professional Survey Report 2019

• レポートコード：QYR9NV09052
• 出版社/出版日：QYResearch / 2019年11月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、110ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥525,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,050,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、新規経口抗凝固剤（NOAC）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、直接トロンビン阻害剤、直接因子Xa阻害剤に、用途別には、深部静脈血栓症（DVT）、肺塞栓症、急性冠症候群、血液透析、その他にセグメント区分し、新規経口抗凝固剤（NOAC）の世界市場を分析しました。

・エグゼクティブ・サマリー
・新規経口抗凝固剤（NOAC）の世界市場概要
・新規経口抗凝固剤（NOAC）の製造コスト構成分析
・新規経口抗凝固剤（NOAC）の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・新規経口抗凝固剤（NOAC）の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・新規経口抗凝固剤（NOAC）のセグメント分析（種類別）
（直接トロンビン阻害剤、直接因子Xa阻害剤）
・新規経口抗凝固剤（NOAC）のセグメント分析（用途別）
（深部静脈血栓症（DVT）、肺塞栓症、急性冠症候群、血液透析、その他）
・新規経口抗凝固剤（NOAC）の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Johnson & Johnson、Bristol-Myers Squibb、Boehringer Ingelheim、Sanofi、Daiichi Sankyo、Armatheon、Aspen、AstraZeneca、Bayer、Cellceutix、Cosmo Pharmaceuticals、CSL Behring、Eisai、GSK、Marathon Pharmaceuticals、Ockham Biotech、Perosphere、）
・新規経口抗凝固剤（NOAC）の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Novel Oral AntiCoagulants (NOAC) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Novel Oral AntiCoagulants (NOAC) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Novel Oral AntiCoagulants (NOAC) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Novel Oral AntiCoagulants (NOAC) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Novel Oral AntiCoagulants (NOAC) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Johnson & Johnson
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Daiichi Sankyo
Armatheon
Aspen
AstraZeneca
Bayer
Cellceutix
Cosmo Pharmaceuticals
CSL Behring
Eisai
GSK
Marathon Pharmaceuticals
Ockham Biotech
Perosphere

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors

Segment by Application
Deep Vein Thrombosis (DVT)
Pulmonary Embolism
Acute Coronary Syndrome
Hemodialysis
Others

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Novel Oral AntiCoagulants (NOAC)
1.1 Definition of Novel Oral AntiCoagulants (NOAC)
1.2 Novel Oral AntiCoagulants (NOAC) Segment by Type
1.2.1 Global Novel Oral AntiCoagulants (NOAC) Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Direct Thrombin Inhibitors
1.2.3 Direct Factor Xa Inhibitors
1.3 Novel Oral AntiCoagulants (NOAC) Segment by Applications
1.3.1 Global Novel Oral AntiCoagulants (NOAC) Consumption Comparison by Applications (2014-2025)
1.3.2 Deep Vein Thrombosis (DVT)
1.3.3 Pulmonary Embolism
1.3.4 Acute Coronary Syndrome
1.3.5 Hemodialysis
1.3.6 Others
1.4 Global Novel Oral AntiCoagulants (NOAC) Overall Market
1.4.1 Global Novel Oral AntiCoagulants (NOAC) Revenue (2014-2025)
1.4.2 Global Novel Oral AntiCoagulants (NOAC) Production (2014-2025)
1.4.3 North America Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.4 Europe Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.5 China Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.6 Japan Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.7 Southeast Asia Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)
1.4.8 India Novel Oral AntiCoagulants (NOAC) Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Novel Oral AntiCoagulants (NOAC)
2.3 Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)
2.4 Industry Chain Structure of Novel Oral AntiCoagulants (NOAC)

3 Development and Manufacturing Plants Analysis of Novel Oral AntiCoagulants (NOAC)
3.1 Capacity and Commercial Production Date
3.2 Global Novel Oral AntiCoagulants (NOAC) Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Novel Oral AntiCoagulants (NOAC)
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Novel Oral AntiCoagulants (NOAC) Production and Capacity Analysis
4.2 Novel Oral AntiCoagulants (NOAC) Revenue Analysis
4.3 Novel Oral AntiCoagulants (NOAC) Price Analysis
4.4 Market Concentration Degree

5 Novel Oral AntiCoagulants (NOAC) Regional Market Analysis
5.1 Novel Oral AntiCoagulants (NOAC) Production by Regions
5.1.1 Global Novel Oral AntiCoagulants (NOAC) Production by Regions
5.1.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Regions
5.2 Novel Oral AntiCoagulants (NOAC) Consumption by Regions
5.3 North America Novel Oral AntiCoagulants (NOAC) Market Analysis
5.3.1 North America Novel Oral AntiCoagulants (NOAC) Production
5.3.2 North America Novel Oral AntiCoagulants (NOAC) Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Novel Oral AntiCoagulants (NOAC) Import and Export
5.4 Europe Novel Oral AntiCoagulants (NOAC) Market Analysis
5.4.1 Europe Novel Oral AntiCoagulants (NOAC) Production
5.4.2 Europe Novel Oral AntiCoagulants (NOAC) Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Novel Oral AntiCoagulants (NOAC) Import and Export
5.5 China Novel Oral AntiCoagulants (NOAC) Market Analysis
5.5.1 China Novel Oral AntiCoagulants (NOAC) Production
5.5.2 China Novel Oral AntiCoagulants (NOAC) Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Novel Oral AntiCoagulants (NOAC) Import and Export
5.6 Japan Novel Oral AntiCoagulants (NOAC) Market Analysis
5.6.1 Japan Novel Oral AntiCoagulants (NOAC) Production
5.6.2 Japan Novel Oral AntiCoagulants (NOAC) Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Novel Oral AntiCoagulants (NOAC) Import and Export
5.7 Southeast Asia Novel Oral AntiCoagulants (NOAC) Market Analysis
5.7.1 Southeast Asia Novel Oral AntiCoagulants (NOAC) Production
5.7.2 Southeast Asia Novel Oral AntiCoagulants (NOAC) Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Novel Oral AntiCoagulants (NOAC) Import and Export
5.8 India Novel Oral AntiCoagulants (NOAC) Market Analysis
5.8.1 India Novel Oral AntiCoagulants (NOAC) Production
5.8.2 India Novel Oral AntiCoagulants (NOAC) Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Novel Oral AntiCoagulants (NOAC) Import and Export

6 Novel Oral AntiCoagulants (NOAC) Segment Market Analysis (by Type)
6.1 Global Novel Oral AntiCoagulants (NOAC) Production by Type
6.2 Global Novel Oral AntiCoagulants (NOAC) Revenue by Type
6.3 Novel Oral AntiCoagulants (NOAC) Price by Type

7 Novel Oral AntiCoagulants (NOAC) Segment Market Analysis (by Application)
7.1 Global Novel Oral AntiCoagulants (NOAC) Consumption by Application
7.2 Global Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Application (2014-2019)

8 Novel Oral AntiCoagulants (NOAC) Major Manufacturers Analysis
8.1 Johnson & Johnson
8.1.1 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.1.2 Johnson & Johnson Product Introduction, Application and Specification
8.1.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb
8.2.1 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.3.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sanofi
8.4.1 Sanofi Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.4.2 Sanofi Product Introduction, Application and Specification
8.4.3 Sanofi Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Daiichi Sankyo
8.5.1 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.5.2 Daiichi Sankyo Product Introduction, Application and Specification
8.5.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Armatheon
8.6.1 Armatheon Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.6.2 Armatheon Product Introduction, Application and Specification
8.6.3 Armatheon Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Aspen
8.7.1 Aspen Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.7.2 Aspen Product Introduction, Application and Specification
8.7.3 Aspen Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 AstraZeneca
8.8.1 AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.8.2 AstraZeneca Product Introduction, Application and Specification
8.8.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Bayer
8.9.1 Bayer Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.9.2 Bayer Product Introduction, Application and Specification
8.9.3 Bayer Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Cellceutix
8.10.1 Cellceutix Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
8.10.2 Cellceutix Product Introduction, Application and Specification
8.10.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Cosmo Pharmaceuticals
8.12 CSL Behring
8.13 Eisai
8.14 GSK
8.15 Marathon Pharmaceuticals
8.16 Ockham Biotech
8.17 Perosphere

9 Development Trend of Analysis of Novel Oral AntiCoagulants (NOAC) Market
9.1 Global Novel Oral AntiCoagulants (NOAC) Market Trend Analysis
9.1.1 Global Novel Oral AntiCoagulants (NOAC) Market Size (Volume and Value) Forecast 2019-2025
9.2 Novel Oral AntiCoagulants (NOAC) Regional Market Trend
9.2.1 North America Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.2 Europe Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.3 China Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.4 Japan Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.5 Southeast Asia Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.2.6 India Novel Oral AntiCoagulants (NOAC) Forecast 2019-2025
9.3 Novel Oral AntiCoagulants (NOAC) Market Trend (Product Type)
9.4 Novel Oral AntiCoagulants (NOAC) Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Novel Oral AntiCoagulants (NOAC) Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Novel Oral AntiCoagulants (NOAC)
Table Global Novel Oral AntiCoagulants (NOAC) Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Types in 2018
Figure Direct Thrombin Inhibitors Product Picture
Figure Direct Factor Xa Inhibitors Product Picture
Table Global Novel Oral AntiCoagulants (NOAC) Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Applications in 2018
Figure Deep Vein Thrombosis (DVT)
Figure Pulmonary Embolism
Figure Acute Coronary Syndrome
Figure Hemodialysis
Figure Others
Figure Global Novel Oral AntiCoagulants (NOAC) Revenue (Million USD) (2014-2025)
Figure Global Novel Oral AntiCoagulants (NOAC) Production (K Units) (2014-2025)
Figure North America Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure Europe Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure China Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure Japan Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Figure India Novel Oral AntiCoagulants (NOAC) Market Size (Million USD) (2014-2025)
Table Novel Oral AntiCoagulants (NOAC) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Novel Oral AntiCoagulants (NOAC) in 2018
Figure Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)
Figure Industry Chain Structure of Novel Oral AntiCoagulants (NOAC)
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Novel Oral AntiCoagulants (NOAC) Manufacturing Plants Distribution
Table Novel Oral AntiCoagulants (NOAC) Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Novel Oral AntiCoagulants (NOAC) Capacity (K Units) of Major Manufacturers (2014-2019)
Table Novel Oral AntiCoagulants (NOAC) Production (K Units) of Major Manufacturers (2014-2019)
Table Novel Oral AntiCoagulants (NOAC) Production Market Share of Major Manufacturers (2014-2019)
Figure Novel Oral AntiCoagulants (NOAC) Production Share by Manufacturers in 2018
Table Novel Oral AntiCoagulants (NOAC) Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Novel Oral AntiCoagulants (NOAC) Revenue Market Share of Major Manufacturers (2014-2019)
Figure Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers in 2018
Table Novel Oral AntiCoagulants (NOAC) Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Novel Oral AntiCoagulants (NOAC) Production by Regions 2014-2019 (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Regions 2014-2019
Figure Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Regions in 2018
Table Global Novel Oral AntiCoagulants (NOAC) Revenue by Regions 2014-2019 (Million USD)
Table Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Regions 2014-2019
Figure Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Regions in 2018
Table Global Novel Oral AntiCoagulants (NOAC) Consumption by Regions 2014-2019 (K Units)
Table Global Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Regions 2014-2019
Figure North America Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure North America Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table North America Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure Europe Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure Europe Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure China Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure China Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table China Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure Japan Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure Japan Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure India Novel Oral AntiCoagulants (NOAC) Production Growth Rate 2014-2019 (K Units)
Figure India Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate 2014-2019 (Million USD)
Table India Novel Oral AntiCoagulants (NOAC) Production, Consumption Import and Export (K Units)
Figure Global Consumption Novel Oral AntiCoagulants (NOAC) Market Share by Application (2014-2019)
Figure Global Value (Consumption) Novel Oral AntiCoagulants (NOAC) Market Share by Application (2014-2019)
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Sanofi Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Sanofi Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Sanofi Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Sanofi Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Sanofi Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Sanofi Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Armatheon Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Armatheon Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Armatheon Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Armatheon Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Armatheon Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Armatheon Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Armatheon Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Aspen Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Aspen Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Aspen Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Aspen Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Aspen Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Aspen Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Aspen Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure AstraZeneca Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table AstraZeneca Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Bayer Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Bayer Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Bayer Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Bayer Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Bayer Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Bayer Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Production Market Share (2014-2019)
Figure Cellceutix Novel Oral AntiCoagulants (NOAC) Revenue Market Share (2014-2019)
Table Cellceutix Novel Oral AntiCoagulants (NOAC) Main Business and Markets Served
Table Cosmo Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table CSL Behring Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Eisai Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table GSK Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Marathon Pharmaceuticals Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Ockham Biotech Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Table Perosphere Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
Figure Global Novel Oral AntiCoagulants (NOAC) Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Novel Oral AntiCoagulants (NOAC) Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Novel Oral AntiCoagulants (NOAC) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Novel Oral AntiCoagulants (NOAC) by Type (2019-2025)
Table Global Consumption (K Units) of Novel Oral AntiCoagulants (NOAC) by Application (2019-2025)
Table Novel Oral AntiCoagulants (NOAC) Distributors List
Table Novel Oral AntiCoagulants (NOAC) Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

抗凝固薬のグローバル市場調査 2019年

Global Anticoagulants Drug Market Professional Survey Report 2019
QYR9NV00804 2019年11月12日 115Pages
※本調査レポートは、抗凝固薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、新規経口抗凝固薬(NOAC)、ワルファリン(VKA)、その他に、用途別には、病院、...

コレラワクチン（経口）のグローバル市場調査 2019年

Global Cholera Vaccine (Oral Route) Market Professional Survey Report 2019
QYR9NV02553 2019年11月12日 104Pages
※本調査レポートは、コレラワクチン（経口）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、シャンコール、デュコラル、ヴァクスチョラ、その他に、用途別には、病院...

口腔ケア及び口腔衛生のグローバル市場：規模・現状・予測2019-2025

Global Oral Care and Oral Hygiene Market Size, Status and Forecast 2019-2025
QYR9NV18242 2019年11月18日 93Pages
※当調査レポートでは、口腔ケア及び口腔衛生の世界市場について調査・分析し、口腔ケア及び口腔衛生の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（歯磨き粉、歯ブラシ、うがい薬、歯科付属品、義歯製品、義歯...

口腔ケア及び口腔衛生のグローバル市場：規模・現状・予測2019-2025

経口＆歯科用プロバイオティクスのグローバル市場調査 2019年

Global Oral & Dental Probiotics Market Professional Survey Report 2019
QYR9NV09293 2019年11月14日 109Pages
※本調査レポートは、経口＆歯科用プロバイオティクスの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、パウダー、チュアブル錠、その他に、用途別には、子供、大人にセ...

経口抗凝固薬のグローバル市場調査 2019年

Global Oral Anticoagulant Market Professional Survey Report 2019
QYR9NV09294 2019年11月14日 109Pages
※本調査レポートは、経口抗凝固薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ワルファリン、ダビガトラン、リバロキサバン、その他に、用途別には、血栓塞栓症、...

経口内視鏡のグローバル市場調査 2019年

Global Oral Endoscopic Market Professional Survey Report 2019
QYR9NV09298 2019年11月14日 107Pages
※本調査レポートは、経口内視鏡の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、直径5.5 mm、直径7 mm、直径8 mmに、用途別には、病院、クリニックにセ...

口腔ヘルペスのグローバル市場調査 2019年

Global Oral Herpes Market Professional Survey Report 2019
QYR9NV09299 2019年11月14日 104Pages
※本調査レポートは、口腔ヘルペスの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ガラス壁、スチール壁に、用途別には、空港、アプリケーションIIにセグメント区分...

ペットオーラルケア製品のグローバル市場調査 2019年

Global Pet Oral Care Products Market Professional Survey Report 2019
QYR9NV09772 2019年11月14日 103Pages
※本調査レポートは、ペットオーラルケア製品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、歯科食品、歯磨き補助剤、フレッシュ呼吸補助剤、その他に、用途別には、...

コレラワクチンオーラルライブのグローバル市場調査 2019年

Global Cholera Vaccines Oral Live Market Professional Survey Report 2019
QYR9NV02554 2019年11月12日 106Pages
※本調査レポートは、コレラワクチンオーラルライブの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、デュコラル、シャンコール、ヴァクスチョラ、その他、に、用途別に...

抗凝固薬のグローバル市場調査 2019年 The global Anticoagulants Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anticoagulants Drug volume and value at global level, regional level and company level. From a global perspective, this…
口腔ケア及び口腔衛生のグローバル市場：規模・現状・予測2019-2025 The increase in the prevalence of dental caries, periodontal diseases, and other dental diseases; growing awareness about oral hygiene; rising dental healthcare expenditure; and increasing number of small/private clinics with dental dispensaries are some of the factors contributing to the growth of …
口腔ケア及び口腔衛生のグローバル市場：規模・現状・予測2019-2025 The increase in the prevalence of dental caries, periodontal diseases, and other dental diseases; growing awareness about oral hygiene; rising dental healthcare expenditure; and increasing number of small/private clinics with dental dispensaries are some of the factors contributing to the growth of …
コレラワクチン（経口）のグローバル市場調査 2019年 The global Cholera Vaccine (Oral Route) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cholera Vaccine (Oral Route) volume and value at global level, regional level and company level. From a global…
経口＆歯科用プロバイオティクスのグローバル市場調査 2019年 The global Oral & Dental Probiotics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Oral & Dental Probiotics volume and value at global level, regional level and company level. From a global perspec…